Kura Oncology, Inc. (KURA) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.00B and a free-cash-flow yield of -7.2%. Over the most recent reported fiscal year, revenue grew 25.2% and free cash flow per share fell 151.9%.